Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2026-02-26 @ 11:14 AM
Study NCT ID:
NCT03755557
Status:
COMPLETED
Last Update Posted:
2020-10-12
First Post:
2018-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray
Sponsor:
Marinomed Biotech AG
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | budesonide | View |
| None | allergic rhinitis | View |
| None | allergic rhinoconjuntivitis | View |
| None | allergen exposure chamber | View |
| None | onset of action | View |
| None | therapeutic equivalence | View |
| None | total nasal symptom score | View |
| None | hayfever | View |
| None | glucocorticosteroids | View |
| None | nasal congestion | View |
| None | Vienna Challenge Chamber | View |
| None | Carragelose | View |
| None | Carrageenan | View |
| None | Iota-Carrageenan | View |